Uliledlimab
Product Specifications
CAS Number
2378407-27-1
Target
CD73|||cAMP
Related Pathways
GPCR/G Protein|||Immunology/Inflammation
Purity
0.955
Bioactivity
Uliledlimab is a humanized monoclonal antibody with potent inhibitory activity against CD73, the ecto-5'-nucleotidase enzyme that catalyzes the conversion of extracellular AMP to adenosine. Uliledlimab reduces extracellular adenosine production, thereby modulating immunosuppressive pathways. Uliledlimab holds significant potential for use in immuno-oncology and cancer research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1134450-01 0.02 mg (E-Coli)
Recombinant Kineococcus radiotolerans Heat-inducible transcription repressor HrcA (hrcA)
Ask
View Details 
MBS1134450-02 0.02 mg (Yeast)
Recombinant Kineococcus radiotolerans Heat-inducible transcription repressor HrcA (hrcA)
Ask
View Details MBS1134450-03 0.1 mg (E-Coli)
Recombinant Kineococcus radiotolerans Heat-inducible transcription repressor HrcA (hrcA)
Ask
View Details MBS1134450-04 0.1 mg (Yeast)
Recombinant Kineococcus radiotolerans Heat-inducible transcription repressor HrcA (hrcA)
Ask
View Details MBS1134450-05 0.02 mg (Baculovirus)
Recombinant Kineococcus radiotolerans Heat-inducible transcription repressor HrcA (hrcA)
Ask
View Details 
MBS1134450-06 0.02 mg (Mammalian-Cell)
Recombinant Kineococcus radiotolerans Heat-inducible transcription repressor HrcA (hrcA)
Ask
View Details